The medical technology marketplace is a constant source of innovation, driven as much by those entrepreneurs who see the need and find the technology solution as those who create
technologies that benefit healthcare delivery and, in turn, create demand.
The types of technologies, the nature of their market impact and the underlying reasons for their success are succinctly described in a white paper from MedMarket Diligence (MMD).
"We have tracked the technologies and their associated markets in the medical device industry, considering not only devices but drug-device hybrids, biomaterials, tissue engineering,
nanotech, biopharmaceuticals and every manner of technology that either competes head-on with medical devices, is integrated with medical devices or, as is sometimes the case, pulls the
rug out from under medical device markets," says Patrick Driscoll, President of MMD. The diversity of the technology types and the manner in which they will impact the medtech market is
breathtaking, according to Driscoll, who sees great cause for enthusiasm by manufacturers, healthcare providers, third party payers, investors and, most importantly, patients.
The MMD white paper on "High Growth Medical Technologies" is available at http://www.mediligence.com/hgmt.htm.
MedMarket Diligence provides tactical decision-making solutions on medical technology to the medical products and investment industries. The company publishes the MedMarkets newsletter, a
monthly analysis of the market implications of new medical technologies, and dedicated reports on technology markets. MedMarkets has identified hundreds of startup companies (many in
stealth mode) and tracks market trends and opportunities emerging from changes in clinical practice, new technology development and other market drivers. For additional details, contact
Patrick Driscoll at email or call 949-859-3401 or toll-free (in the U.S.). 1-866-820-1357.